Clinical Trial Update: Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update examining the combination of anlotinib and sintilimab as first-line treatment for advanced non-liver metastatic colorectal cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Sintilimab (sintilimab)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING